A client receiving cholestyramine for hyperlipidemia should be evaluated for vitamin K and folate ( a form of vitamin B) deficiency.
Hyperlipidemia is a condition whereby there are high levels of fat particles (cholesterol and triglycerides) in the blood. These substances can deposit on the walls of blood vessels and can restrict or completely block the flow of blood, increasing the risk of heart attack and stroke.
Cholestyramine is administered to people who haven't been able to lower their cholesterol naturally despite dietary changes to help reduce high LDL cholesterol ( the bad cholesterol ) levels in the blood. It works by combining with bile acids in the intestine, stopping it from being recycled. Therefore, cholesterol in the body is converted to bile acids which lowers the body's cholesterol.
However, low fat in the blood means the body is unable to properly absorb fat soluble vitamins ( vitamins that are only soluble in fat ) like vitamin K. Hence, a client being treated with cholestyramine should be evaluated for a deficiency for this vitamin. The client should additionally be evaluated for deficiency in other fat soluble vitamins like vitamins A, D, E and folate.
To learn more about hyperlipidemia and it's treatment, check; brainly.com/question/9003800
#SPJ4
